These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38863282)

  • 1. Intended and Actual Participation in the Colorectal Cancer Screening Program.
    Dreier M; Brinkmann M; Stahmeyer JT; Hemmerling M; Krauth C; Walter U
    Dtsch Arztebl Int; 2024 Jul; 121(15):497-504. PubMed ID: 38863282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
    Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
    Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Bowel Cancer: Increasing Participation via Personal Invitation.
    Hoffmeister M; Holleczek B; Zwink N; Stock C; Stegmaier C; Brenner H
    Dtsch Arztebl Int; 2017 Feb; 114(6):87-93. PubMed ID: 28266301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.
    Bauer A; Riemann JF; Seufferlein T; Reinshagen M; Hollerbach S; Haug U; Unverzagt S; Boese S; Ritter-Herschbach M; Jahn P; Frese T; Harris M; Landenberger M
    Dtsch Arztebl Int; 2018 Oct; 115(43):715-722. PubMed ID: 30518470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
    Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
    Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental disorders, participation, and trajectories in the Danish colorectal cancer programme: a population-based cohort study.
    Thomsen MK; Jørgensen MD; Pedersen L; Erichsen R; Sørensen HT; Mikkelsen EM
    Lancet Psychiatry; 2023 Jul; 10(7):518-527. PubMed ID: 37353263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
    Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors to Improve Endoscopic Screening for Colorectal Cancer.
    Malgazhdarov MS; Madyarov VM; Kaliaskarov YS; Kaliyeva ZZ; Isabekov NA
    J Gastrointest Cancer; 2021 Mar; 52(1):289-293. PubMed ID: 32303997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening: Associations between information provision, attitudes and intended participation.
    Brandhof SD; Fagerlin A; Hawley S; Toes-Zoutendijk E; Trevena L; McCaffery K; Korfage IJ
    Patient Educ Couns; 2018 Mar; 101(3):546-550. PubMed ID: 28899711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
    Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
    [No Abstract]   [Full Text] [Related]  

  • 19. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.